Comparing outcomes of different treatment regimens for severe haemophilia.
about
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.SPINART study: validation of the extended magnetic resonance imaging scale for evaluation of joint status in adult patients with severe haemophilia A using baseline data.Clinical utility and patient perspectives on the use of extended half-life rFIXFc in the management of hemophilia B.Musculoskeletal evaluation in severe haemophilia A patients from Latin America.Persons with Haemophilia in Sweden- Experiences and Strategies in Everyday Life. A Single Centre StudyDose and response in haemophilia--optimization of factor replacement therapy.Can early subclinical gait changes in children with haemophilia be identified using the GAITRite walkway.Primary prophylaxis in children with haemophilia.Cost-effectiveness of prophylaxis against on-demand treatment in boys with severe hemophilia A in Iran.Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management.On-demand treatment in persons with severe haemophilia.Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis.European retrospective study of real-life haemophilia treatment.Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART).Patient and parent preferences for characteristics of prophylactic treatment in hemophilia.Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B.Comparing the burden of illness of haemophilia between resource-constrained and unconstrained countries: the São Paulo-Toronto Hemophilia Study.Factors affecting the Haemophilia Joint Health Score in children with severe haemophilia.Haemophilia in Poland.Iranian Low-dose Escalating Prophylaxis Regimen in Children with Severe Hemophilia A and B.A survey of the outcome of prophylaxis, on-demand or combined treatment in 20-35 year old men with severe haemophilia in four European countries.Prophylactic treatment effects on inhibitor risk: experience in one centre.Haemophilia and joint disease: pathophysiology, evaluation, and management.
P2860
Q30539596-BDBA3803-99F8-4C7D-9023-E4A91C62B85BQ31131582-9CB64AEB-4FA0-45B9-9BF8-FF8953A67F57Q34045763-BB32EEFA-60C1-49EB-9BCF-89E4AE1F3508Q34844510-45BE88FF-D8E4-4CB3-9D9F-71A6996435ABQ35797283-91999AA7-EE1E-4266-8FE7-9E514C196A49Q35895845-724CC8DE-20BB-4BF4-B806-45B094CBC55FQ36945950-98427B58-AC42-4DA9-B322-196536B0FFBAQ37119644-A8A30827-B0DB-4F54-88AE-2A928AABE26BQ37619008-85865354-FCF1-4E4A-82DD-E5C06385BD45Q37952373-9FBB1F66-6B27-4220-820A-091A3732C84CQ38222575-4B35DA79-8587-46C6-9187-BEB3E6A81246Q38227605-A58736D6-C959-4B25-B2CB-42058E669F76Q39268322-631B4B75-E371-4F23-8888-0E57BD60FAC1Q42693839-49B318C9-B836-415F-93E5-FF23382E2A6FQ43148985-9BA62C0D-43BC-4439-B832-3531D8277458Q44051815-73AFE3D6-CE13-49C2-8486-CD8F404AA0FAQ44871911-D1703C89-1334-4262-97FD-B5D5AE75896FQ45038280-BFFD9AE6-FEEE-4979-AEF9-A897C93FFF79Q45855087-6B9EDD39-D0BC-43F9-8AB2-8112364F9DC2Q45863340-C6A3F7A8-DF67-45DB-B31E-C637844D3881Q45870706-38540990-65AD-49AF-B046-B5F168F35FFFQ45882431-72411E23-EF3F-41AB-AA47-75507309249BQ55004994-3062F0AF-516C-4AED-AD30-3E3EDA079531
P2860
Comparing outcomes of different treatment regimens for severe haemophilia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Comparing outcomes of different treatment regimens for severe haemophilia.
@en
Comparing outcomes of different treatment regimens for severe haemophilia.
@nl
type
label
Comparing outcomes of different treatment regimens for severe haemophilia.
@en
Comparing outcomes of different treatment regimens for severe haemophilia.
@nl
prefLabel
Comparing outcomes of different treatment regimens for severe haemophilia.
@en
Comparing outcomes of different treatment regimens for severe haemophilia.
@nl
P2860
P1433
P1476
Comparing outcomes of different treatment regimens for severe haemophilia.
@en
P2093
van den Berg HM
van der Bom JG
P2860
P304
27-31; discussion 31
P356
10.1046/J.1365-2516.9.S1.10.X
P478
P577
2003-05-01T00:00:00Z